IL6 and neoplasm: Dynamic MYCN gene expression is an integrated consequence of multiple signals in the tumor microenvironment, including tumor stemness/growth-promoting signals such as Wnt/β-catenin and IL-6-STAT3 signaling, lipid desaturation-mediated ER stress adaptation signals, and tumor suppressive miRNAs.